health

IASO Biotherapeutics closes $108 million Series C financing

IASO Biotherapeutics is a biopharmaceutical company. The nanjing-based company closed a Series C financing round of $108 million.

AccuRx raised $38 million in a Series B funding round

AccuRx raised $38 million in a Series B funding round. The company has now raised a total of $49.9 million to date.

Health tech startup HexaHealthpicks up $1.5 million in Seed funding

HexaHealth is a health tech startup. The startup picks up $1.5 million from eight investors in Seed funding.

Previous page Next page